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A B S T R A C T
Q fever is a zoonosis caused by the rickettsial organism Coxiella burnetii. Infection has an acute course,
usually with a self-limited febrile illness and the possibility of the evaluation to a chronic course with
endocardial involvement. The presence of autoantibodies and various autoimmune disorders have also
been associated with C. burnetii infection. We report a case of acute Q fever in which the patient
developed large vessel vasculitis. The FDG-PET/CT scan detected inﬂammation of the thoracic aortic wall,
suggesting an unusual immunologic host response to acute Q fever infection.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Q fever is a zoonosis caused by Coxiella burnetii, a strict
intracellular bacterium that lives in host phagocytic cells and
exhibits multiple ways of interaction with the innate and adaptive
immune system of the host [1,2].
Q fever can be acute or chronic and may present with a wide
spectrum of clinical manifestations, occasionally mimicking
various autoimmune diseases, with autoantibodies being fre-
quently present during its course [3,4,5].
We report a case of acute Q fever related with imaging and
clinical features of Takayasu’s arteritis.
Case report
A 60 year old woman was admitted in the Department of
Internal Medicine because of a 15 day history of intermittent fever
of 38 8C, aching pain over the forehead and fatigue. She reported no
rigors, arthralgias, nausea, vomiting rash, postnasal drip, cough,
diarrhea, urinary symptoms and any other pain or weight loss.
At the onset of fever, she had been referred to another clinic
where she was thought to suffer from some infection. White blood
cell count was 11,500/ml, ESR 50 mm/h and CRP 7 mg/dl (normal* Corresponding author. Tel.: +302106867377.
E-mail address: e.giamarellou@hygeia.gr (H. Giamarellou).
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3.0/).value <0.5 mg/dl). However, blood and urine cultures were sterile,
CT imaging of the brain, sinus, chest and abdomen-pelvis showed
no sites of infection and transthoracic echocardiography was
normal. Her fever resolved without antibiotics, and after her
discharge on the ﬁfth hospital day she stayed afebrile for a further 5
days before her symptoms recurred.
The patient had no other medical history. She mentioned
trekking as a hobby and had been on vacation to Cyprus 2 months
earlier. She had no known allergies, had never smoked and had no
recent exposure to ill persons.
When she presented to our Department, clinical examination
conﬁrmed temperature of 38.2 8C while all other vital signs were
normal. There was no neck stiffness and the remainder of the
neurologic examination was normal. Chest was clear on ausculta-
tion but she had a 2/6 systolic murmur at the mitral area which
was not present at her previous hospitalization. There were no
hepatosplenomegaly, lymphadenopathy, abdominal tenderness or
masses. She had no skin lesions and temporal arteries were
clinically normal bilaterally.
Laboratory analysis revealed raised ESR (100 mm/h) and CRP
(17 mg/dl – normal value <0.5). White cell count was 10,000 mm3
with 72% neutrophils and 21% lymphocytes. Hemoglobin was 12 g/
dl and platelet count 200,000/mm3. Electrolytes, total protein,
albumin, globulin, uric acid and LDH were normal, as were tests of
coagulation, renal and liver function.
Six sets of blood cultures were obtained from different sites at
the peak of fever and when she was afebrile, and trans-esophageale under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 1. Increased uptake of FDG in the ascending aorta, aortic arch and thoracic
descending aorta.
Table 1
Coxiella burnetii antibodies of the patient.
Coxiella burnetii antibodies
Phase I Phase II
IgG IgM IgG IgM
27/2/2013 1/256 Negative 1/1024 1/64
19/3/2013 1/256 1/32 1/512 1/128
21/9/2013 1/512 1/16 1/1024 1/16
30/1/2014 1/64 Negative 1/256 Negative
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endocarditis. Blood cultures were all sterile, however TEE showed a
small mitral lesion which resembled vegetation. No abnormality or
serious regurgitation of the valve was noticed.
These ﬁndings were considered indicative of blood culture
negative infective endocarditis. Treatment with intravenous
ceftriaxone 2 g was administered focusing on the HACEK group
of bacteria. Further diagnostic tests were pursued for fastidious
organisms including brucella agglutinin tests (Wright, Wright
Coombs), serologic tests for C. burnetii, Bartonella, Chlamydia,
Mycoplasma, as well PCR for Tropheryma whippelii. Prolonged
incubation of the blood cultures was requested to address the
possibilities of HACEK pathogens, and nutritionally deﬁcient
streptococci (Abiotrophia defective, Granulicatella). The LightCycler
SeptiFast test was also performed to detect, as a multiplex real-
time PCR assay, possible bacteria or fungi causing bloodstream
infection.
All tests were negative except for the screening test for C.
burnetii. An IgG anti-phase II antibody titer of 1/1024 and an IgM
anti-phase II antibody titer of 1/64 were detected. Anti-phase I
antibodies were IgG 1/256 whereas IgM as well as PCR were found
negative (National Reference Center of Parasitology Zoonoses and
Geographical Medicine in Heraklion-Crete). These results were
strongly indicative of acute Q fever. It is established in the
literature that endocarditis is the major clinical manifestation of
chronic Q fever. As a result, our ﬁrst estimation of endocarditis
based on the TEE ﬁndings and the diagnosis of acute Q fever were
contradictory. Considering the febrile course and positive serology,
treatment was changed from ceftriaxone to doxycycline 100 mg
bid plus hydroxychloroquine 600 mg daily, in case of evolution to
chronic Q fever. After 7 days of treatment, the fever persisted. Even
more, the patient presented with more frequent and higher peaks
of fever up to 38.5 8C which did not respond to regular non-
steroidal anti-inﬂammatory drugs. The patient appeared unwell
and laboratory analysis revealed a further rise of inﬂammatory
markers (ESR: 120 mm/h and CRP: 22 mg/ml) and worsening
anemia of chronic disease. Renal and liver function remained
normal. A second TEE showed the same mitral valve lesion.
Therefore, further work-up was performed.
Serum ferritin level was 400 ng/ml (normal range 10–291 ng/
ml), not markedly raised to suggest adult-onset Still’s disease. PCR
assay for CMV was negative as was the serologic test for HIV and
the quantiferon test as evidence of latent tuberculosis. The AgK39
for leishmaniasis was also negative. Temporal artery biopsy was
normal and bone marrow analysis revealed a reactive marrow with
no signs of inﬁltration or granuloma. Endoscopy of the gastroin-
testinal tract and biopsies did not suggest inﬂammatory bowel
disease. Investigations for the possibility of a systemic autoim-
mune disease were requested: serum complement levels were
normal; antinuclear antibodies were borderline weak positive at 1/
80, anti-dsDNA, ANCA, RF Factor and all other autoantibodies were
negative, with the exception of IgM anticardiolipin antibodies and
the anti b2 GPI IgM antibodies, which were twice the normal
values.
The patient’s constitutional symptoms, valvular involvement,
raised inﬂammatory markers and some positive autoantibodies
suggested the possibility of a non infectious systemic inﬂamma-
tory process. FDG-PET/CT scan was requested, which revealed
increased uptake of FDG (indicating any kind of inﬂammation) in
the ascending aorta, aortic arch and thoracic descending aorta,
strongly suggestive of the presence of a large vessel vasculitis/
aortitis (Fig. 1). We concluded that our patient was suffering from
acute Q fever, complicated by aortitis. Treatment with intravenous
methylprednisolone, 1 g daily for 3 days was initiated. The patient
became afebrile within 24 h, inﬂammatory markers returned to
normal and her general status improved markedly and rapidly.Serological follow up, 21 days after the ﬁrst screening, conﬁrmed
the diagnosis of acute Q fever. An IgG anti-phase II antibody titer of
1/512 and an IgM anti-phase II antibody titer of 1/128 were
detected, whereas an IgG anti-phase I antibody was only 1/256
(Table 1). The patient recovered and she was discharged from
hospital on 15 mg of methotrexate once a week, 32 mg of
methylprednisolone per day to be tapered, 200 mg of doxycycline
and 600 mg of hydroxychloroquine daily, for at least 1 year.
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Two aspects of our case warrant discussion. First, the probable
relation between an infection and a non-infectious inﬂammatory
disease. Second, the treatment strategy and follow-up of the
patient.
At the onset of the disease, we were confronted with an unusual
combination of serologic diagnosis of acute Q fever and a subtle
mitral valve lesion. The phase II IgM and IgG antibodies were 1/64
and 1/1024 indicating recent Q fever infection. However, according
to the modiﬁed Duke criteria, endocarditis is associated with
antiphase I IgG antibody titer >1/800 [6].
It is well accepted that patients with symptomatic acute Q fever
usually present with ﬂu-like symptoms and fever which is
accompanied by severe headaches. Moreover one quarter of acute
Q fever patients experience a biphasic fever, as was noticed in this
case [1]. Atypical pneumonia, hepatitis and meningoencephalitis
are further major forms of acute Q fever [2]. Cardiac involvement
has been infrequently reported in acute Q fever patients and
involves myocarditis and pericarditis [1]. Endocarditis is the main
clinical manifestation of chronic Q fever, whereas infections of
aneurysms and vascular grafts have also been described. Recently
FDG-PET/CT has been utilized for estimation of vascular infections
due to chronic Q fever [1,3,7].
The patient presented a strong inﬂammatory reaction which
resulted in positive ACL and anti b2 GPI IgM antibodies. In this new
setting, the atypical valvular vegetation could be attributed to non-
bacterial thrombotic endocarditis of the Libman-Sacks type.
Moreover the FDG-PET/CT scan detected inﬂammation of the
thoracic aortic wall. The image was strongly indicative of an
aortitis, like Takayasu’s arteritis [8], and was not classiﬁed as
aneurysm or probable localization of infection. A variety of
autoantibodies have been described in acute Q fever including
antibodies to phospholipids, antimitochondrial antibodies, anti
smooth muscle, antinuclear and antiSm antibodies [4,5,9].
Moreover, dysregulation of cytokines and different host responses
in acute Q fever patients have been documented [10,11]. Recently,
seven cases of Q fever were reported, mimicking vasculitis,
systemic inﬂammatory disease or autoimmune disorder. Q fever
was acute in 4 of the 7 patients, and the initial presentations
suggested Crohn’s disease, Good-pasture syndrome, polymyalgia
rheumatica and adult-onset Still’s disease, polyarteritis nodosa,
giant-cell arteritis and essential type II cryoglobulinemia [4].
In particular antibodies to phospholipids are a common
immunologic event in the setting of Q fever. Their activity is
usually b2GP1-independent (infectious type a PL) and rarely
associated with thrombotic events [4,12]. Furthermore, it has been
reported that chronic Q fever may mimic large or medium sized
vessel vasculitis [12]. However, in this case it seems that acute Q
fever triggered an intense immunologic process which resulted in
the damage of the valve tissue and the inﬂammation of the thoracic
aortic wall, with an image from the FDG-PET/CT similar to that of
Takayasu’s arteritis. The clinical presentation of this disease may
range from non speciﬁc constitutional symptoms to carotidynia
and total cerebrovascular events with aneurysms and aortic
rupture [13]. Its pathogenesis remains unknown and both
immunologic mechanisms and genetic predisposition seem to
be involved. In this case, it is interesting to speculate that the host
response to acute Q fever associated with the early expression of
the Takayasu’s-type vasculitis. It is recommended that in such
cases, patients may beneﬁt from steroid treatment [4,9,10], with
high dosage and a long course of steroids often required [10,11].
Therefore, we assumed that our patient was suffering from acute Q
fever and also developed an immunologically-mediated valvular
defect and inﬂammatory involvement of the aorta. There is great
concern regarding the management of such patients. Followingprimary infection, there should be high clinical suspicion of the
patient developing chronic Q fever. The chronic evolution of acute
state and reactivation of Q fever in this case is challenging,
regarding the pre-existing valvular and vascular defect. Moreover
the long-term immunomodulatory therapy for the vasculitis may
increase the risk for the patient to develop an insidious, chronic
infection [9].
It is estimated that the risk of evolution from acute Q fever to
chronic Q fever with endocarditis is 40% in patients with
underline valvulopathy [14]. In the later case, combination of
doxycycline plus hydroxychloroquine is preferred for preventing
the development of endocarditis than doxycycline monotherapy.
Therefore, we decided that our patient should be treated with
doxycycline plus hydroxychloroquine for at least 12 months, while
receiving methotrexate and a tapering course of steroids for
continuing control of her aortitis. Methotrexate was considered
necessary as a steroid sparing treatment for the suppression of the
inﬂammation and preservation of vascular competence of the
ascending and thoracic aorta. In addition, we decided serological
follow-up every 2 months (as recommended for methotrexate
treatment monitoring) and a TEE every 3 months for at least 2
years should be performed [13,15]. The patient was advised at
discharge to be monitored clinically, initially every 3 months, then
every 6 months for 2–3 years and then yearly for life [16,17]. As far
as the vasculitis of aorta is concerned, clinical monitoring,
inﬂammatory markers and the FDG-PET/CT imaging were sug-
gested for monitoring disease activity and response to treatment
[13].
Eighteen months later, the patient has discontinued doxycy-
cline, hydroxychloroquine and methylprednisolone as well,
whereas she is ongoing maintenance therapy with 15 mg
methotrexate in order to suppress the immunological reaction
of the vasculitis. She remains well with no clinical or laboratory
evidences of ongoing inﬂammatory disease activity. The TEE has
not been changed as far as it concerns the mitral valve lesion,
whereas a recent FDG-PET/CT revealed no uptake at all, without




Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
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